Stephen Keane

Mr. Keane is a seasoned life sciences executive with an extensive track record in business development and financial transactions for emerging biopharmaceutical companies. He has experience as CBO, COO, and CEO of several Venture Capital funded companies, including officer roles in publicly traded companies. Keane has raised over $420 million in equity capital in the last two decades and has helped generate more than $450 million in non-dilutive partner revenues to fund drug discovery programs. He was responsible for negotiating multiple acquisitions, alliances including licenses, distributions agreements, technology acquisitions, and research agreements with large pharmaceutical companies and government agencies. His more than 25-year track record with successful biotechnology companies demonstrates his ability to navigate the drug development pathway and raise adequate capital for development and successful exits for their investors.